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A B S T R A C T
An increasing number of anaerobic bacteremias of oral origin have been described 
during the recent years as a cause of fever in neutropenic cancer patients. In this 
paper, we describe a case of Prevotella buccae bacteremia, the first one to our know-
ledge, emphasizing thus the importance of considering the oral commensals when 
selecting antimicrobial regimens.
I N T R O D U C T I O N
Any organism, even what is thought to be a harmless commensal, has the poten-
tial to cause significant infections in cancer neutropenic patients. “New” pathogens 
emerged in the past few years as a result of the potent chemotherapeutic regimens 
[1]. We describe a case of febrile neutropenia, due to Prevotella buccae bacteremia, 
which, to our knowledge, is the first in the literature.
C A S E  R E P O R T
A 24-year-old man, with an acute myeloid leukemia in complete remission, un-
derwent a conditioning regimen, consisting of melphalan, fludarabine, antithymocyte 
globulin and total body irradiation, before the allogeneic bone marrow transplantation. 
As infection prophylaxis, ciprofloxacin, trimethoprim/sulfamethoxasole, itraconazol 
and acyclovir were administered. On day 10 of the post-chemotherapy period, the 
patient developed fever (38.3°C), without rigors, and signs of hemodynamic decom-
pensation. He complained also of dysphagia and retrosternal pain. Mild oral mucositis 
was present with probable esophagitis, but esophagoscopy was not performed. With the 
exception of severe neutropenia (<50/mm3) and thrombocytopenia (11,000/mm3), no 
other severe abnormalities were detected in his hematological and biochemical profile. 
Urine examination and chest x-ray were normal. Three sets of blood cultures were 
drawn and treatment with piperacillin/tazobactam 4gr qid IV was initiated. The stem 
cells were infused the day after and two days later the temperature was normalized. 
All blood cultures revealed Prevotella buccae.
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M I C R O B I O L O G I C A L  D A T A
Specimens were processed using the BACTEC 9240 non-
radiometric continuous monitoring blood culture system. All 
three blood culture sets had the anaerobic bottles lagged as 
positive on day two; two aerobic bottles also turned positive 
on days seven and eight. Direct examination of the smear 
revealed Gram negative rods. The aliquot was subcultured 
onto Columbia blood agar 5% SB both aerobically and an-
aerobically and onto Schaedler 5% SB supplemented with 
Vitamin K1 anaerobically. The ANOXOMAT system was 
used as anaerobic environment while the BBL Crystal Iden-
tification System (Anaerobe ID kit) was also used. Antibiotic 
susceptibility testing was done on the basis of Kirby Bauer disk 
diffusion. The germ proved to be intermediately resistant to 
penicillin and susceptible to the other agents tested (amoxi-
cillin-clavulanate, piperacillin-tazobactam, clindamycin, 
imipenem, metronidazole).
D I S C U S S I O N
The relatively new genus Prevotella, named so in 1990, 
was previously included in the genus Bacteroides. It includes 
saccharolytic pigmented and non- pigmented anaerobic 
gram negative rods. Prevotella, along with Bacteroides spp., 
are numerically the most prevalent organisms of the normal 
human bacterial flora. Most species are encountered mainly 
in the oral cavity and the pharynx, but the alimentary and 
the female genital tract are also normal habitats for some of 
them [2-4]. Prevotella spp., usually as part of a mixed flora, 
are implicated in dental, oropharyngeal, pleuropulmonary, 
abdominal and gynaecological infections [5-9]. They are not 
a frequent cause of bacteremia. In an analysis of 281,797 con-
secutive blood cultures performed at the Mayo Clinic over 
an eight-year period (1984-92), among the 20,456 probable 
pathogens detected, only 28 (0.1%) were Prevotella spp. [10]. 
In the Jules Bordet Institute, only three Prevotella spp. have 
been isolated in blood cultures over the past six years, while the 
total number of positives was approximately 1150. Resistance 
to beta-lactams is secondary to beta-lactamase production 
and is encountered in 40% of isolates [3]. Prevotella buccae 
is a non pigmented, pentose fermenting species. It is a com-
mensal of oropharynx and is mainly involved in dental, oral 
and respiratory infections [2,3,7,8,11]. Furthermore, only one 
case of clinically significant bacteremia due to P.buccae was 
identified by searching in MEDLINE [12].
It is well known that normal oral commensals, both aero-
bic and anaerobic, gain access to the blood stream through 
breaches of the mucosa in cancer neutropenic patients. The 
selective pressure of quinolone prophylaxis and the profound 
and prolonged neutropenia along with the oral lesions (mainly 
due to post-chemotherapy mucositis but also to infections and 
bleeding) resulted in the emergence of new pathogens. Some 
of these germs, considered of low virulence, proved to be liable 
for the cause of clinically significant bacteremias [1]. Strepto-
coccus viridans remains the most commonly involved germ of 
the oral flora, but Stomatococcus mucilaginosus [13], Capno-
cytophaga spp. [14], Leptotrichia bucallis [15], Eubacterium 
spp. [16] and Fusobacterium spp. [17] have also been reported 
in recent years as etiologic agents of febrile neutropenia. In the 
Jules Bordet Institute, S. mucilaginosus and Fusobacterium 
spp. proved to be responsible for 5.3% and 5% of bacteremias 
in febrile neutropenic patients [13,17]. It is the first time that 
Prevotella buccae bacteremia is recognized as a cause of fe-
brile neutropenia. All aforementioned predisposing factors 
were present. No special symptoms or signs were detected, 
and the evolution was benign, comparable to that attested in 
our Fusobacterium series [17].
In summary, one more oral anaerobe, Prevotella buc-
cae, proved to be a potential pathogen in granulocytopenic 
patients and it is possible that this will be the case for more 
commensals of the mouth. This emphasises the need of mea-
sures for prevention and control of the mucositis. Clinicians, 
therefore, have to be aware of the spectrum and the suscep-
tibility patterns of these germs. In case of mucositis, if fever 
persists, despite first line empirical therapy lacking specific 
antianaerobic activity, the pathogens should be covered, even 
if cultures are negative. It seems that combinations of beta-
lactams and beta-lactamase inhibitors are efficient, safe and 
probably cost effective.
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